Benzene: Toxic chemical leaves legacy of blood cancers.

For many workers suffering from acute myeloid leukemia or myelodysplastic syndrome, their disease is related to benzene exposure on the job. Benzene is a highly toxic chemical that is widely used for dozens of industrial purposes. Workers exposed to benzene over a lengthy period of time are at particular risk for developing a variety of blood diseases, including cancer.

Benzene is among the twenty chemicals used most in American industrial applications. At times, benzene has a sweet smell, and at others, it has no odor at all. In a liquid form at room temperature, benzene has a light yellow color. In its gaseous form, benzene may appear like a colorless fog. Benzene is highly flammable.

Benzene is found naturally in crude oil. As a result, many refined petroleum products contain benzene, including gasoline, other fuels, solvents, paint and glue. In addition, benzene is widely used in the manufacture of many substances and products, such as plastics, rubbers, resins, lubricants, dyes, detergents, pesticides, and more.

Since the 1920s, medical experts have been publicizing the relationship between benzene and leukemia. By the 1930s, workers exposed to benzene in the printing industry were known to be at risk for blood disease. In the 1940s, an American Petroleum Institute study cautioned that no “safe” level of benzene exposure exists. Yet still, in the decades since then, untold numbers of workers have been exposed in the workplace to dangerous levels of benzene.

Those at the greatest risk for benzene-related illnesses are workers exposed every day to the benzene contained in fuels, solvents and other products. Workers likely to have experienced prolonged exposure include chemical and petroleum industry workers, printers, painters, mechanics, railroad workers, rubber workers, seamen and many others.

Most workers exposed to benzene inhale the dangerous toxin. But workers can also suffer significant exposure when they get solvents or fuels on their hands. Benzene is particularly dangerous because it can take years from the time workers are exposed before they develop any symptoms of benzene-related blood cancers.

Benzene exposure causes a great number of health problems. When exposure is sudden and acute, it can cause anything from drowsiness to death. But when benzene exposure is chronic at lower levels, it more often leads over time to the development of blood-related illnesses. Two conditions that have been most closely linked to the toxic substance are acute myeloid leukemia (AML) and myelodysplastic syndrome.

Benzene-Related Acute Myeloid (or Myelogenous) Leukemia (AML)

Acute myeloid leukemia attacks bone tissue involved in the formation of blood cells.

AML Symptoms

In the early stages, AML’s symptoms are similar to flu symptoms:

  • Aching bones
  • Bleeding from the gums or nosebleeds
  • Bruising easily
  • Fatigue
  • Fever
  • Repeated infections
  • Pale skin and
  • Shortness of breath.

AML progresses quickly if not treated, so if you are experiencing these symptoms and you’ve had benzene exposure, get in touch with your doctor as soon as possible.

AML Diagnosis
Your doctor will conduct several tests to learn the cause of your symptoms:

  • Blood tests, which if positive for AML will show the presence of more white blood cells than normal along with fewer red blood cells and platelets;
  • Bone marrow biopsy, in which the doctor extracts a bone marrow sample from the hipbone for testing; and
  • Lumbar puncture (spinal tap), which removes fluid through a needle in the lower back to look for leukemia cells.

If the doctor diagnoses AML, you will likely see a specialist — an oncologist, who treats cancer patients, or a hematologist, who treats blood-related diseases — who will decide upon treatment options.

AML Treatment
AML treatment depends on the type of disease and the extent to which it has progressed as well as your age and overall health. For most people, treatment involves two phases:

  • Remission Induction Therapy. Traditional AML treatment’s first phase aims to destroy as many cancer cells as possible. The treatment usually involves chemotherapy, though some forms of AML also respond well to a combination of chemotherapy and other anti-cancer drugs.
  • Maintenance Therapy. Because remission induction therapy usually does not kill off all the cancer cells, AML treatment also includes maintenance therapy (also called consolidation or post-remission therapy or intensification). Maintenance therapy often relies on further chemotherapy. Recently diagnosed AML patients may also receive a stem cell, or bone marrow, transplant either from a compatible donor (allogeneic transplant) or from the patient’s own healthy stem cells harvested during remission (autologous transplant).

For some patients, doctors recommend participation in an AML clinical trial studying an alternative, experimental therapy instead of the traditional AML treatment.

Myelodysplastic Syndrome (MDS)
Myelodysplastic syndromes are a group of blood conditions involving a problem in the bone marrow, causing it to make dysfunctional or immature blood cells that either die before they ever leave the bone marrow or soon after they enter the bloodstream.

MDS Symptoms
MDS symptoms, which usually appear only at the later stages of the disease, include:

  • Excessive bleeding and/or bruising;
  • Fatigue;
  • Infections;
  • Pale skin;
  • Red pindots just beneath the skin (petechiae); and
  • Shortness of breath.

MDS Diagnosis
Tests that confirm the presence of MDS commonly include some or all of the following:

  • Complete blood count, which tallies the number of blood cells contained in a blood sample;
  • Peripheral blood smear, which is examined for abnormalities in blood cells’ appearance, shape or size; and
  • Bone marrow biopsy, which withdraws bone marrow and a sliver of bone through a thin needle inserted into the hipbone to examine the material for abnormalities.

MDS Treatments
Doctors are still working on a cure for myelodysplastic syndromes. Treatments to manage MDS symptoms and complications include:

  • Growth factor medications. These may increase the number of the body’s red blood cells, which could reduce the need for blood transfusions. Other growth factors boost white blood cell production which helps prevent infection.
  • Medications to stimulate cell maturity. These may help blood cells grow to maturity, which improves quality of life and may help to delay development of acute myelogenous leukemia (AML).
  • Medications to suppress the immune system.
  • Medications to prevent the need for blood transfusions.
  • Bone marrow/stem cell transplant. This procedure is risk-prone for the older patients who usually develop MDS. It replaces dysfunctional bone marrow cells with healthy cells from a compatible donor (allogeneic transplant) or from the patient’s own healthy stem cells harvested during remission (autologous transplant).
  • Healthy living. MDS patients benefit by developing habits to prevent infection, such as frequent hand-washing, thoroughly washing and cooking food and staying away from people who are sick.

How Waters Kraus Paul & Siegel can protect your interests

For three decades, the lawyers at Waters Kraus Paul & Siegel have been representing people who have been sickened by toxic chemicals. If you (or a loved one) have been exposed to benzene and diagnosed with acute myeloid leukemia or myelodysplastic syndrome, contact us or call 800.226.9880 to speak with an experienced benzene lawyer today.

Workers at risk for benzene exposure

  • Adhesive Makers
  • Airplane Dope Makers
  • Alcohol Workers
  • Aniline Makers
  • Art Glass Workers
  • Artificial Leather Makers
  • Asbestos Product Impregnators
  • Asphalt Mixers
  • Automotive Workers
  • Battery (Dry) Makers
  • Belt Scourers
  • Brakelining Makers
  • Bronzers
  • Burnishers
  • Can Makers
  • Carbolic Acid Makers
  • Cast Scrubbers
  • Chemical Synthesis
  • Clutch Disc Impregnators
  • Coal Tar Workers/Refineries
  • Cobblers
  • Coke Oven Workers
  • DDT Makers
  • Degreasers
  • Detergent Makers
  • Disinfectant Makers
  • Drug Makers
  • Dry Cleaners
  • Dye Makers
  • Electroplaters
  • Enamelers
  • Engravers
  • Explosive Makers
  • Fabric Dyers
  • Feather Workers
  • Fuel Handlers
  • Fumigant Makers
  • Fungicide Makers
  • Furniture Finishers
  • Gas Workers
  • Glue Makers
  • Hair Dressers
  • Herbicide Makers
  • Histology Techs
  • Hydrochloric Acid Workers
  • Ink Makers
  • Insecticide Makers
  • Lacquer Makers
  • Leather Makers
  • Linoleum Makers
  • Lithographers
  • Maleic Acid Makers
  • Millinery Worker
  • Mirror Silverers
  • Mordanters
  • Oil Processors
  • Oilcloth Maters
  • Organic Chemical Synthesizers
  • Paint Makers
  • Painters
  • Paraffin Processors
  • Pencil Makers
  • Perfume Makers
  • Petrochemical Workers
  • Pharmaceutical Workers
  • Photographic Chemical Makers
  • Picric Acid Makers
  • Polish Makers
  • Pottery Decorators
  • Printers
  • Putty Makers
  • Rubber Reclaimers
  • Resin Makers
  • Respirator Makers
  • Rotogravure Printers
  • Rubber Cementers
  • Rubber Gasket Makers
  • Rubber Makers
  • Shellac Makers
  • Shoe Factory Workers
  • Shoe Finishers
  • Soap Makers
  • Solvent Makers
  • Stainers
  • Styrene Makers
  • Tobacco Seedling Treaters
  • Type Cleaners
  • Varnish Makers
  • Vulcanizers
  • Wax Makers
  • Welders
  • Window Shade Makers
  • Wire Insulators

$725M Benzene Verdict Against Exxon Earns National Media Attention

June 6, 2024 Waters Kraus Paul & Siegel partners Patrick Wigle and Rajeev Mittal and Locks Law Firm partner Andrew DuMont were named among Law360’s “Lions of the Week” for their $725.5 million toxic exposure verdict against ExxonMobil. The May 9 verdict in…

Three from Waters Kraus Paul & Siegel recognized by Super Lawyers Rising Stars

June 13, 2024 Waters Kraus Paul & Siegel is proud to announce that firm attorneys Chris Johnson, Caitlyn Silhan and Camille Hunt have been honored among the nation’s top lawyers under 40 by Thomson Reuters’ 2024 “Super Lawyers – Rising Stars.” Each year,…

Three from Waters Kraus Paul & Siegel recognized by Super Lawyers Rising Stars

June 13, 2024 Waters Kraus Paul & Siegel is proud to announce that firm attorneys Chris Johnson, Caitlyn Silhan and Camille Hunt have been honored among the nation’s top lawyers under 40 by Thomson Reuters’ 2024 “Super Lawyers – Rising Stars.” Each year, Super Lawyers conducts a rigorous selection process designed to identify outstanding early and mid-career lawyers in each state. Attorneys practicing in more than 70 practice areas are selected based on peer nominations and a rigorous vetting process designed to recognize the top 2.5 percent of practicing lawyers under age 40 or who have been in practice fewer than 10 years.…

What are my chances?

That’s the first question everyone asks. The truth is it’s impossible to know. But we can tell you this. Waters Kraus Paul & Siegel has what it takes to fight against big corporate interests and win. That’s why we’ve taken more mesothelioma trials to verdict than any other firm. And that’s why we’ve recovered more than $1.3 billion for clients like you. Do you think you have a case? Contact us now to speak with an attorney.

Call 800.226.9880